Bruker BRKR Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.
The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bruker's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bruker's redeemable NCI?
- Bruker (BRKR) reported redeemable NCI of $35.8M in Q1 2026.
- How has Bruker's redeemable NCI changed year-over-year?
- Bruker's redeemable NCI increased by 95.6% year-over-year, from $18.3M to $35.8M.
- What does redeemable NCI mean?
- Equity in subsidiaries held by others that the company may be required to buy back for cash.
- How do you interpret redeemable NCI?
- An increase represents a higher potential future cash obligation, which may impact liquidity and capital allocation flexibility.
- How does redeemable NCI compare across companies?
- Common in companies that grow through acquisitions of partial stakes in specialized technology firms.